Luca Ricotti

512 total citations
22 papers, 440 citations indexed

About

Luca Ricotti is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luca Ricotti has authored 22 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luca Ricotti's work include Cancer Treatment and Pharmacology (8 papers), Cancer therapeutics and mechanisms (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Luca Ricotti is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Cancer therapeutics and mechanisms (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Luca Ricotti collaborates with scholars based in Italy and United States. Luca Ricotti's co-authors include Wainer Zoli, Anna Tesei, D. Amadori, Giovanni Luca Frassineti, Dino Amadori, Paola Ulivi, Donata Casadei Giunchi, M. Dal Susino, Francesco� Fabbri and Franca De Paola and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Luca Ricotti

22 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Ricotti Italy 11 226 189 102 81 45 22 440
Hanan Ahmed Wahba Egypt 8 238 1.1× 226 1.2× 94 0.9× 140 1.7× 53 1.2× 24 529
Hend Ahmed El-Hadaad Egypt 9 243 1.1× 241 1.3× 105 1.0× 140 1.7× 63 1.4× 25 552
Ronald Drengler United States 13 487 2.2× 296 1.6× 104 1.0× 70 0.9× 38 0.8× 27 701
Mingzhu Huang China 13 157 0.7× 211 1.1× 99 1.0× 111 1.4× 54 1.2× 36 422
Y.-H. Ling United States 13 226 1.0× 333 1.8× 84 0.8× 44 0.5× 25 0.6× 24 582
J. H. M. Schellens Netherlands 12 281 1.2× 156 0.8× 83 0.8× 59 0.7× 26 0.6× 18 506
Leeona Galligan United Kingdom 8 264 1.2× 384 2.0× 73 0.7× 87 1.1× 23 0.5× 9 591
Thomas A. Lampkin United States 9 259 1.1× 410 2.2× 75 0.7× 84 1.0× 31 0.7× 11 631
Vincent A. de Weger Netherlands 11 334 1.5× 211 1.1× 94 0.9× 67 0.8× 27 0.6× 26 551
Katherine Kravik Norway 9 306 1.4× 358 1.9× 64 0.6× 128 1.6× 43 1.0× 11 652

Countries citing papers authored by Luca Ricotti

Since Specialization
Citations

This map shows the geographic impact of Luca Ricotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Ricotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Ricotti more than expected).

Fields of papers citing papers by Luca Ricotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Ricotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Ricotti. The network helps show where Luca Ricotti may publish in the future.

Co-authorship network of co-authors of Luca Ricotti

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Ricotti. A scholar is included among the top collaborators of Luca Ricotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Ricotti. Luca Ricotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ulivi, Paola, Wainer Zoli, Francesco� Fabbri, et al.. (2005). Cellular Basis of Antiproliferative and Antitumor Activity of the Novel Camptothecin Derivative, Gimatecan, in Bladder Carcinoma Models. Neoplasia. 7(2). 152–161. 14 indexed citations
2.
Zoli, Wainer, Paola Ulivi, Anna Tesei, et al.. (2005). Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines. Breast Cancer Research. 7(5). R681–9. 73 indexed citations
3.
Ricotti, Luca, Anna Tesei, Carlo Milandri, et al.. (2003). Potentiation of Antiproliferative Drug Activity by Lonidamine in Hepatocellular Carcinoma Cells. Journal of Chemotherapy. 15(5). 480–487. 10 indexed citations
4.
Ibrahim, Toni, M. Fabbri, Giovanni Luca Frassineti, et al.. (2003). Doxorubicin, Paclitaxel and Gemcitabine: a Phase I Study of a New Sequential Treatment in Stage III B - IV Breast Cancer. Journal of Chemotherapy. 15(5). 488–494. 5 indexed citations
5.
Ricotti, Luca, Anna Tesei, Franca De Paola, et al.. (2003). In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines.. PubMed. 9(2). 900–5. 33 indexed citations
6.
Zoli, Wainer, M. Dal Susino, Luca Ricotti, et al.. (2002). Simultaneous determination of apoptosis and surface antigen expression in tumor adherent cells.. PubMed. 15(4). 359–65. 5 indexed citations
7.
Zoli, Wainer, M. Dal Susino, Anna Tesei, et al.. (2002). Flow-Cytometric Determination of Tumor Cells in Lymph Nodes<footref rid="foot01"><sup>1</sup></footref>. Oncology. 62(2). 128–135. 8 indexed citations
8.
Frassineti, Giovanni Luca, Toni Ibrahim, Wainer Zoli, et al.. (2002). Docetaxel Followed by Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer: A Phase I Study. Tumori Journal. 88(2). 99–103. 3 indexed citations
9.
Tesei, Anna, Luca Ricotti, Franca De Paola, et al.. (2002). In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell lines.. PubMed. 8(1). 233–9. 25 indexed citations
10.
Zoli, Wainer, et al.. (2001). In vitro preclinical models for a rational design of chemotherapy combinations in human tumors. Critical Reviews in Oncology/Hematology. 37(1). 69–82. 59 indexed citations
11.
Tesei, Anna, et al.. (2000). Lanreotide-Induced Modulation of 5-Fluorouracil or Mitomycin C Cytotoxicity in Human Colon Cancer Cell Lines: a Preclinical Study. Journal of Chemotherapy. 12(5). 421–430. 4 indexed citations
12.
Ricotti, Luca, Anna Tesei, D. Amadori, et al.. (2000). Combined 4-hydroxy-ifosfamide and vinorelbine treatment in established and primary human breast cell cultures. Annals of Oncology. 11(5). 587–594. 5 indexed citations
13.
Calistri, Daniele, M. Dal Susino, Luca Saragoni, et al.. (2000). Correlation between p53 gene mutations and p53 protein accumulation evaluated by different methodologies.. PubMed. 14(2). 120–7. 4 indexed citations
14.
Zoli, Wainer, Luca Ricotti, M. Dal Susino, et al.. (1999). Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines. International Journal of Cancer. 80(3). 413–416. 66 indexed citations
15.
Zoli, Wainer, Luca Ricotti, M. Dal Susino, et al.. (1999). Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer. British Journal of Cancer. 81(4). 609–615. 45 indexed citations
16.
Zoli, Wainer, Luca Ricotti, M. Dal Susino, et al.. (1999). Schedule‐dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines. International Journal of Cancer. 80(3). 413–416. 1 indexed citations
17.
Maltoni, Marco, Annalisa Volpi, Oriana Nanni, et al.. (1999). Gastric cancer: epidemiologic and biological aspects.. PubMed. 8(2). 199–207. 3 indexed citations
18.
Bertoni, Livia, Wainer Zoli, Luca Ricotti, et al.. (1998). Different Genome Organization in Two New Cell Lines Established from Human Gastric Carcinoma. Cancer Genetics and Cytogenetics. 105(2). 152–159. 12 indexed citations
19.
Gasperi‐Campani, Anna, Laura Roncuzzi, Luca Ricotti, et al.. (1998). Molecular and Biological Features of Two New Human Squamous and Adenocarcinoma of the Lung Cell Lines. Cancer Genetics and Cytogenetics. 107(1). 11–20. 17 indexed citations
20.
Zoli, Wainer, Luca Ricotti, Luca Lenzi, et al.. (1998). Molecular Genetics and In Vitro Sensitivity of a New Human Cell Line, KKP, from a Gastric Adenocarcinoma. Cancer Genetics and Cytogenetics. 105(1). 43–49. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanan Ahmed Wahba Breakdown of academic impact, for papers by Hend Ahmed El-Hadaad Breakdown of academic impact, for papers by Ronald Drengler Breakdown of academic impact, for papers by Mingzhu Huang Breakdown of academic impact, for papers by Y.-H. Ling Breakdown of academic impact, for papers by J. H. M. Schellens Breakdown of academic impact, for papers by Leeona Galligan Breakdown of academic impact, for papers by Thomas A. Lampkin Breakdown of academic impact, for papers by Vincent A. de Weger Breakdown of academic impact, for papers by Katherine Kravik
Rankless by CCL
2026